SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17179166
Source:
http://linkedlifedata.com/resource/pubmed/id/17179166
Search
Subject
(
76
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0016701
,
umls-concept:C0225336
,
umls-concept:C0796392
,
umls-concept:C1280500
,
umls-concept:C1442989
,
umls-concept:C1548793
pubmed:issue
6
pubmed:dateCreated
2007-5-18
pubmed:abstractText
Bevacizumab is an antiangiogenic compound developed to target tumour vessels. Its off-label use in ophthalmology requires in vitro testing on ocular cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-11344092
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-11678628
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-12360282
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-14685874
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15625332
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15664960
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15886877
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15911882
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15936441
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16156141
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16156152
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16156153
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16170134
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16399431
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16458968
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16603955
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16770255
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-17021318
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-17021319
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-3782302
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-7526212
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-7536000
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-7673356
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-9801894
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0421041
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal
,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized
,
http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0007-1161
pubmed:author
pubmed-author:AdlerMartinM
,
pubmed-author:Bartz-SchmidtKarl-UlrichKU
,
pubmed-author:GrisantiSalvatoreS
,
pubmed-author:HeiduschkaPeterP
,
pubmed-author:JulienSylvieS
,
pubmed-author:PetersSwaantjeS
,
pubmed-author:SchraermeyerUlrichU
,
pubmed-author:ZiemssenFockeF
pubmed:issnType
Print
pubmed:volume
91
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
827-31
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17179166-Angiogenesis Inhibitors
,
pubmed-meshheading:17179166-Animals
,
pubmed-meshheading:17179166-Antibodies, Monoclonal
,
pubmed-meshheading:17179166-Antibodies, Monoclonal, Humanized
,
pubmed-meshheading:17179166-Capillary Permeability
,
pubmed-meshheading:17179166-Cell Proliferation
,
pubmed-meshheading:17179166-Cells, Cultured
,
pubmed-meshheading:17179166-Choroid
,
pubmed-meshheading:17179166-Dose-Response Relationship, Drug
,
pubmed-meshheading:17179166-Drug Stability
,
pubmed-meshheading:17179166-Endothelial Cells
,
pubmed-meshheading:17179166-Endothelium, Vascular
,
pubmed-meshheading:17179166-Freezing
,
pubmed-meshheading:17179166-Swine
pubmed:year
2007
pubmed:articleTitle
Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.
pubmed:affiliation
University Eye Hospital, Eberhard-Karls University Tuebingen, Schleichstrasse 12, D-72076 Tuebingen, Germany. swaantje.peters@gmx.de
pubmed:publicationType
Journal Article